Stocks / TGTX / EPS (Earnings per Share)

TG Therapeutics, Inc. EPS (Earnings per Share) 2011–2025

TG Therapeutics, Inc. reported $2.77 of earnings per share for fiscal 2025. That was 1746.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +214.5%.

Latest filed value
$2.77
One-year change
+1746.7%
Change since 2020
+214.5%
Latest period end
2025
TG Therapeutics, Inc. EPS (Earnings per Share) history from 2011 to 2025FY 2011: 0FY 2012: 0FY 2013: 0FY 2014: 0FY 2015: 0FY 2016: 0FY 2017: 0FY 2018: 0FY 2019: 0FY 2020: -2.42FY 2021: -2.63FY 2022: -1.65FY 2023: 0.09FY 2024: 0.15FY 2025: 2.77
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearEPS (Earnings per Share)Change (YoY)
FY 2025$2.77+1746.7%
FY 2024$0.15+66.7%
FY 2023$0.09+105.5%
FY 2022$-1.65+37.3%
FY 2021$-2.63-8.7%
FY 2020$-2.42
FY 2019$0.00
FY 2018$0.00
FY 2017$0.00
FY 2016$0.00
FY 2015$0.00
FY 2014$0.00
FY 2013$0.00
FY 2012$0.00
FY 2011$0.00

Source: TG Therapeutics, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TGTX 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

TG Therapeutics, Inc. reported $2.77 of earnings per share for fiscal 2025. That was 1746.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +214.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for TG Therapeutics, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

TG Therapeutics, Inc. — frequently asked questions

What is TG Therapeutics, Inc.'s earnings per share?

TG Therapeutics, Inc. (TGTX) reported earnings per share of $2.77 for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from TG Therapeutics, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.

More TGTX financial history

Full TGTX fundamentals page → · Analyze earnings per share with a free tool → · All 1,500+ companies →